Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 2,951.31%42.57M | -502.71%-6.23M | 1,524.85%19.26M | -703.82%-12.03M | -1,518.79%-8.15M | 8.07%-1.49M | -121.61%-1.03M | -104.39%-1.35M | 151.53%1.99M | -238.13%-503.46K |
| Net income from continuing operations | 33.95%-3.38M | 57.88%-1.17M | -33.17%-1.6M | 99.83%-21K | 301.08%9.08M | -238.81%-5.11M | 41.77%-2.79M | 22.43%-1.2M | -436.41%-12.36M | -444.28%-4.51M |
| Operating gains losses | -97.08%50K | -42.08%-996K | 104.53%131K | -579.08%-11.13M | -492.88%-9.25M | 164.51%1.71M | ---701K | ---2.89M | --2.32M | --2.35M |
| Depreciation and amortization | -89.74%35K | -84.32%53K | -89.28%37K | -88.10%242K | -302.97%-782K | -25.37%341K | -37.32%338K | -47.13%345K | -18.76%2.03M | -59.37%385.29K |
| Remuneration paid in stock | 412.93%595K | 164.86%294K | -10.43%249K | -45.63%572K | -64.19%67K | -61.50%116K | -53.39%111K | -14.59%278K | -38.49%1.05M | -20.87%187.09K |
| Other non cashItems | 2,019.02%50.03M | -97.94%51K | 1,625.12%25.07M | -109.75%-352K | -793.14%-6.64M | 167.62%2.36M | 154.43%2.48M | 82.68%1.45M | 33.63%3.61M | 8.80%958.25K |
| Change In working capital | -422.37%-4.76M | -847.66%-4.45M | -796.98%-4.62M | -125.14%-1.34M | -593.47%-621K | -201.59%-912K | -109.05%-470K | 174.67%663K | 162.87%5.33M | 104.18%125.84K |
| -Change in receivables | -422.89%-5.21M | -543.22%-4.27M | -626.91%-4.76M | -125.86%-1.62M | -1,689.80%-860K | -183.37%-996K | -113.31%-664K | 674.05%903K | 193.93%6.25M | 98.42%-48.05K |
| -Change in prepaid assets | -104.00%-51K | -175.81%-94K | 255.88%53K | -34.92%82K | -50.51%17K | 79.14%-25K | -16.38%124K | -153.78%-34K | -88.16%126K | 781.88%34.35K |
| -Change in payables and accrued expense | 354.13%495K | -227.14%-89K | 140.78%84K | 118.61%195K | 59.09%222K | 161.58%109K | 22.15%70K | 80.71%-206K | 63.68%-1.05M | 221.69%139.54K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 2,951.31%42.57M | -502.71%-6.23M | 1,524.85%19.26M | -703.82%-12.03M | -1,518.79%-8.15M | 8.07%-1.49M | -121.61%-1.03M | -104.39%-1.35M | 151.53%1.99M | -238.13%-503.46K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -2,541.67%-23.78M | -6,633.33%-29.29M | -2,628.38%-16.15M | -360.27%-8.97M | -1,798.08%-7.04M | -133.57%-900K | 41.51%-435K | -32.13%-592K | 93.84%-1.95M | 85.99%-370.85K |
| Net PPE purchase and sale | -2,871.71%-24.16M | -6,368.74%-28.14M | -1,889.02%-11.78M | -129.26%-4.47M | -608.10%-2.63M | -110.99%-813K | 41.51%-435K | -32.13%-592K | 93.84%-1.95M | 85.99%-370.85K |
| Net other investing changes | --3.71M | ---1.15M | ---4.38M | ---4.5M | ---4.41M | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -2,541.67%-23.78M | -6,633.33%-29.29M | -2,628.38%-16.15M | -360.27%-8.97M | -1,798.08%-7.04M | -133.57%-900K | 41.51%-435K | -32.13%-592K | 93.84%-1.95M | 85.99%-370.85K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 861.90%480K | -98.61%218K | 217.95%46K | 34,293.92%61.89M | 117,533.26%46.37M | -58.61%-63K | 34,515.33%15.63M | 30.84%-39K | -100.70%-181K | 29.60%-39.48K |
| Net issuance payments of debt | 0.00%-38K | 4.88%-39K | 5.13%-37K | 14.36%-155K | 6.29%-37K | 4.33%-38K | 9.71%-41K | 30.84%-39K | 31.56%-181K | 29.60%-39.48K |
| Net common stock issuance | --0 | ---- | ---- | --65.75M | --49.06M | --0 | ---- | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | --518K | --257K | --83K | --752K | --752K | --0 | --0 | --0 | --0 | ---- |
| Net other financing activities | ---- | ---- | ---- | ---4.46M | ---3.41M | ---25K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 861.90%480K | -98.61%218K | 217.95%46K | 34,293.92%61.89M | 117,533.26%46.37M | -58.61%-63K | 34,515.33%15.63M | 30.84%-39K | -100.70%-181K | 29.60%-39.48K |
| Net cash flow | ||||||||||
| Beginning cash position | -20.47%13.24M | 1,782.76%48.27M | 889.21%45.01M | -2.75%4.6M | 162.81%14.35M | 121.41%16.64M | -35.53%2.56M | -2.77%4.55M | -77.86%4.73M | 4.28%5.46M |
| Current changes in cash | 884.81%19.28M | -349.28%-35.3M | 259.25%3.16M | 29,951.82%40.9M | 3,511.71%31.18M | -19.86%-2.46M | 254.73%14.16M | -70.08%-1.98M | 98.57%-137K | 60.93%-913.79K |
| Effect of exchange rate changes | -122.22%-36K | 420.99%260K | 3,666.67%107K | -7,014.29%-484K | -15,957.79%-562K | 2,169.76%162K | 82.07%-81K | -100.65%-3K | 100.10%7K | -99.80%3.54K |
| End cash Position | 126.32%32.48M | -20.47%13.24M | 1,782.76%48.27M | 879.31%45.01M | 879.31%45.01M | 162.81%14.35M | 121.41%16.64M | -35.53%2.56M | -1.79%4.6M | -1.79%4.6M |
| Free cash from | 898.35%18.41M | -2,240.94%-34.37M | 485.24%7.49M | -37,586.36%-16.49M | -1,132.51%-10.78M | -14.76%-2.31M | -136.36%-1.47M | -75.21%-1.94M | 100.12%44K | 61.70%-874.31K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.